940 related articles for article (PubMed ID: 27837775)
1. The Gut Microbiota: The Gateway to Improved Metabolism.
Martinez KB; Pierre JF; Chang EB
Gastroenterol Clin North Am; 2016 Dec; 45(4):601-614. PubMed ID: 27837775
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
3. The microbiota-gut-brain axis in obesity.
Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota: a target for intervention in obesity.
Sehgal K; Khanna S
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome approaches to treat obesity in humans.
Bianchi F; Duque ALRF; Saad SMI; Sivieri K
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
[TBL] [Abstract][Full Text] [Related]
6. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
8. Strategies to increase the efficacy of using gut microbiota for the modulation of obesity.
Li J; Riaz Rajoka MS; Shao D; Jiang C; Jin M; Huang Q; Yang H; Shi J
Obes Rev; 2017 Nov; 18(11):1260-1271. PubMed ID: 28742949
[TBL] [Abstract][Full Text] [Related]
9. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota as a therapeutic target for obesity: a scoping review.
Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and metabolic syndrome.
Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
[TBL] [Abstract][Full Text] [Related]
12. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
13. Diet effects in gut microbiome and obesity.
Chen J; He X; Huang J
J Food Sci; 2014 Apr; 79(4):R442-51. PubMed ID: 24621052
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
15. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
Barengolts E
Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
[TBL] [Abstract][Full Text] [Related]
16. Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.
Edwards PT; Kashyap PC; Preidis GA
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G382-G390. PubMed ID: 32755308
[TBL] [Abstract][Full Text] [Related]
17. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
[TBL] [Abstract][Full Text] [Related]
18. An overview of microbiome based strategies on anti-obesity.
Chang CS; Ruan JW; Kao CY
Kaohsiung J Med Sci; 2019 Jan; 35(1):7-16. PubMed ID: 30844145
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
20. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
